Intellipharmaceutics International Inc. (IPCI) SEC Filing 20-F Annual report for the fiscal year ending Friday, November 30, 2012

Intellipharmaceutics International Inc.

CIK: 1474835 Ticker: IPCI

View differences made from one year to another to evaluate Intellipharmaceutics International Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Intellipharmaceutics International Inc..


Assess how Intellipharmaceutics International Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Intellipharmaceutics International Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: IPCI
CIK: 1474835
Form Type: 20-F Annual Report
Accession Number: 0001171843-13-000353
Submitted to the SEC: Thu Jan 31 2013 4:26:16 PM EST
Accepted by the SEC: Thu Jan 31 2013
Period: Friday, November 30, 2012
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: